Vitiligo and social acceptance

Bidaki, Reza and Majidi, Niloofar and Ahmadi, Amir Moghadam and Bakhshi, Hamid and Mohammadi, Rezvan Sadr and Mostafavi, Seyed-Ali and Arababadi, Mohammad Kazemi and Hadavi, Maryam and Mirzaei, Afshin (2018) Vitiligo and social acceptance. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 11. pp. 383-386.

[img]
Preview
Text
Vitiligo and social acceptance.pdf

Download (137kB) | Preview

Abstract

Background and aim: Vitiligo is a chronic skin disease characterized by a total or partial loss of melanocytes from the epidermis and other tissues of the skin. It is placed in the class of secondary psychiatric disorders and can also lead to psychological problems. The main aim of this study was to assess social acceptance in vitiligo patients. Methods: This cross-sectional study was conducted on all of the patients (n=150) with vitiligo who were referred to dermatology clinics in Rafsanjan, Iran. The patients completed a social acceptability questionnaire (Marlowe-Crowne Social Desirability Scale), and information regarding their demographic characteristics was also collected. Data were gathered and analyzed with descriptive and inferential statistics using SPSS-19 software. Results: The mean age of the patients was 27.56 +/- 10.53 years and 65.9% were female. Mean score of social acceptance among the patients was 13.51 +/- 7.08. The results showed that the mean scores of social acceptance were significantly lower in women, in those with single marital status, in those with face and neck lesions, and in those with disease duration less than 5 years. Conclusion: The results showed that certain groups of patients with vitiligo are at greater risk of experiencing lower social acceptance.

Item Type: Article
Subjects: R Medicine > RL Dermatology
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: sobhan rezaiian
Date Deposited: 01 Sep 2018 10:17
Last Modified: 01 Sep 2018 10:17
URI: http://eprints.lums.ac.ir/id/eprint/1357

Actions (login required)

View Item View Item